Connect with us

Hi, what are you looking for?

press release

Bragar Eagle & Squire, PC examines Compass, EyePoint, – Press Release

NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. CMPEyePoint Pharmaceuticals, Inc. EYPTF45 Training Holdings, Inc. FXLVand PROG Holdings, Inc. PRG. Our investigations address whether these companies have violated federal securities laws and/or engaged in other illegal business practices. For more information on each case, see the link provided.

Compass Minerals International, Inc. CMP

On September 23, 2022, the United States Securities and Exchange Commission (“SEC”) announced that Compass was ordered to pay $12 million to settle “misleading investor” fees by repeatedly asserting that a technology update at its flagship salt mine, “on track to significantly reduce costs and increase operating results beginning in 2018,” when in reality costs at the mine were increasing significantly. [undermining] the projected savings.” The SEC also found that Compass had overstated the amount of salt it could produce.

On the news, Compass stock fell $1.58, or 4.1%, to close at $36.88 per share on September 23, 2022.

For more information on the Compass investigation, visit: https://bespc.com/cases/CMP

EyePoint Pharmaceuticals, Inc. EYPT

On August 30, 2022, after the market close, EyePoint announced that it had received a subpoena from the United States Attorney for the District of Massachusetts. The subpoena requested documents covering the company’s sales practices for its post-surgical inflammation treatment DEXYCU.

As a result of this news, EyePoint stock fell $0.21 per share, or 2%, to close at $10.00 per share on August 31, 2022.

For more information on the EyePoint exam, visit: https://bespc.com/cases/EYPT

F45 Training Holdings, Inc. FXLV

On or about July 15, 2021, F45 Training completed its initial public offering (“IPO”), selling 18.75 million shares at a price of $16.00 per…

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...